Cardiovascular risk reduction with liraglutide: an exploratory mediation analysis of the LEADER trial
Buse JB, Bain SC, Mann JFE, et al.
Diabetes Care. 2020;43(7):1546-52
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Type 2 diabetes and HbA1c are independently associated with wider retinal arterioles: the Maastricht study
Li W, Schram MT, Berendschot TTJM, et al.
Diabetologia. 2020;63:1408-417
Leggi
A performance score of the quality of inpatient diabetes care is a marker of clinical outcomes and suggests a cause‐effect relationship between hypoglycaemia and the risk of in‐hospital mortality
Dei Cas A, Aldigeri R, Ridolfi V, Vazzana A, Ciardullo AV, Manicardi V, Sforza A, Tomasi F, Zavaroni D, Zavaroni I, Bonadonna RC
Diabetes Metab Res Rev. Pub. online 22 May 2020
Leggi
Use of GLP-1RAs in type 2 diabetes and cardiovascular disease
Honigberg MC, Chang LS, McGuire DK, et al.
JAMA Cardiol. Pub. online 17 June 2020
Leggi
Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study
Kohsaka S, Lam CSP, Kim DJ, et al.
Lancet Diabetes Endocrinol. 2020;8(7):606-615.
Leggi
Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes. A randomized clinical trial
Pratley RE, Kanapka LG, Rickels MR, et al.
JAMA. 2020;323(23):2397-2406.
Leggi
Effect of continuous glucose monitoring on glycemic control in adolescents and young adults with type 1 diabetes
Laffel LM, Kanapka LG, Beck RW, et al.
JAMA. 2020;323(23):2388-2396.
Leggi
Statins in primary prevention of cardiovascular disease – should we start while young and healthy?
Fabijanic D,Luksic B, Ljubkovic M
The American Journal of Cardiology. Pub. online 10 June 2020
Leggi
Patient‐reported outcomes after 10‐year follow‐up of intensive, multifactorial treatment in individuals with screen‐detected type 2 diabetes: the ADDITION‐Europe trial
Dalsgaard EM, Sandbæk A, Griffin SJ, et al.
Diabetic Medicine. Pub. online 12 June 2020
Leggi
Increased risk of type 2 diabetes in antidepressant users: evidence from a 6‐year longitudinal study in the E3N cohort
Da Silva MA, Fournier A, Boutron‐Ruault MC, et al.
Diabetic Medicine. Pub. online16 June 2020
Leggi